-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Greenwich LifeSciences, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2019 to Q2 2024.
- Greenwich LifeSciences, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$2.66M, a 52.3% decline year-over-year.
- Greenwich LifeSciences, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$10.5M, a 13.7% decline year-over-year.
- Greenwich LifeSciences, Inc. annual Operating Income (Loss) for 2023 was -$9.33M, a 16% decline from 2022.
- Greenwich LifeSciences, Inc. annual Operating Income (Loss) for 2022 was -$8.04M, a 74.9% decline from 2021.
- Greenwich LifeSciences, Inc. annual Operating Income (Loss) for 2021 was -$4.6M, a 147% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)